Chasteberry (Vitex) and PMS

What 4 graded rows on chasteberry (vitex) agree on for PMS, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Chasteberry (Vitex) page, with its PubMed record.

Your question

Supplement
Chasteberry (Vitex) Choose another

Chasteberry (Vitex) and PMS

4 rows · 1,060 people

They agree: all 4 rows found an improvement.

No difference
Each block is one evidence row, sized by how many people it enrolled, with its grade inside.
  • Grade B× 3
  • Grade C× 1
Rows
4
Trials
6
People
1,060
Pooled reviews may count some twice

What the rows share

From the rows

The best-graded row, grade B, is a meta-analysis of 520 people (2019) and found an improvement.

The rows run from 162 to 520 people, published from 2001 to 2019: 1 pooled review and 3 single studies.

The rows

4 improved
  1. Grade BPMS remission (responder rate) · Improved

    Meta-analysis, 3 studies · n 520 · 2019 · Women with PMS in double-blind trials of well-characterized extracts

    As in the pooled trials · Up to 3 menstrual cycles

    Women on chasteberry were 2.57 times as likely to have symptom remission as those on placebo (95% CI 1.52–4.35). Only 3 of 21 trials met reporting standards for inclusion.

    Row on the Chasteberry (Vitex) page · PubMed 31780016 (opens PubMed)

  2. Grade BPMS diary and PMTS scores · Improved

    RCT · n 208 · 2009 · Chinese women with moderate to severe premenstrual syndrome

    Extract corresponding to 40 mg of dried fruit daily · 3 menstrual cycles

    PMS diary score fell by 22.7 points vs 15.5 with placebo. The authors reported a placebo effect of about 50%. No serious adverse events.

    Row on the Chasteberry (Vitex) page · PubMed 19269753 (opens PubMed)

  3. Grade BPMS symptom score and responder rate · Improved

    RCT · n 170 · 2001 · Women with premenstrual syndrome in German community clinics (mean age 36)

    One tablet daily (mg per tablet not stated in the abstract) · 3 menstrual cycles

    Symptom scores (irritability, mood, anger, headache, breast fullness, bloating) improved more than with placebo; 52% vs 24% had at least a 50% drop. Mild side effects in 4 vs 3 women.

    Row on the Chasteberry (Vitex) page · PubMed 11159568 (opens PubMed)

  4. Grade CPMS total symptom score by dose · Improved

    RCT · n 162 · 2012 · Women aged 18–45 with premenstrual syndrome

    8, 20 or 30 mg/day vs placebo · 3 menstrual cycles

    20 mg/day improved symptoms more than placebo and 8 mg; 30 mg was not better than 20 mg. All doses were well tolerated.

    Row on the Chasteberry (Vitex) page · PubMed 23022391 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.